PRE-MARKET CHINESE STOCKS NEWS: Hong Kong markets reopen from long weekend and get opportunity to react to China's cross-border investment crackdown
China Film Co. (600977 CH) - Co.’s chairman will resign effective May 25 due to the age limit. (Newswires)
China Medical System Holdings (867 HK) - Co. was granted approval in China to conduct a clinical trial for CMS-D001. (Newswires)
China National Chemical Engineering (601117 CH) - Co. reported April new contracts of CNY 128.5bln vs CNY 114.9bln M/M. (Newswires)
China Ruifeng Renewable Energy (527 HK) - Trading in Co.’s shares was halted on HKEX. (Newswires)
CK Hutchison (1 HK) - Co.’s AS Watson is reportedly still planning a USD 30bln dual IPO in Hong Kong and London. (Newswires)
SSY Group (2005 HK) - Co. obtained first bulk drug registration approval in China for Safinamide Mesylate. (Newswires)
Wasion Group (3393 HK) - Co.’s subsidiary secured overseas business contracts exceeding RMB 1.6bln since the start of 2026, primarily covering infrastructure and related solutions for data centres. (Newswires)
WuXi Biologics (2269 HK) - Co. announced share buybacks worth up to USD 400mln, to be conducted in the open market. (Newswires)
Other News
China announced a major crackdown on cross-border investment on Friday and said it would punish brokers it accused of illegally moving money to foreign markets. It was separately reported that Citic said the CSRC’s crackdown on cross-border trading involves USD 32bln in Hong Kong assets. (Newswires/SCMP)